Rite Aid Addresses Cyberattack: 2.2 Million Customers’ Data Breached
Drug Topics
JULY 17, 2024
The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Drug Topics
JULY 17, 2024
The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.
Drug Topics
AUGUST 29, 2022
Using electronic medical record data from 2018-2020 obtained from 24 medical centers across the US, including Johns Hopkins, University of Colorado, and Mayo Clinic institutions, a new study suggests rates of youth onset type 2 diabetes increased 77% during the first year of the pandemic.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 13, 2024
Researchers studied the effect of wildfires on mental health in California from 2011 to 2018.
Fierce Healthcare
JANUARY 24, 2023
Hospital, health system boards saw low turnover, slow diversity gains from 2018-2022, AHA finds dmuoio Tue, 01/24/2023 - 10:23
PhRMA
JUNE 14, 2023
year-over-year in 2022, continuing a trend in which 340B sales have almost doubled since 2018, outpacing growth of the total U.S. The 340B Drug Pricing Program has grown yet again , exceeding $100 billion in sales in 2022 when 340B-priced medicines are measured at wholesale acquisition cost. Recent data from IQVIA shows 340B grew 12.2%
Drug Topics
JUNE 6, 2024
Overdose deaths have decreased for the first time since 2018, but naloxone remains an important tool in fighting the opioid epidemic.
Drug Topics
NOVEMBER 28, 2023
The World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) Cancer Prevention Recommendations were updated in 2018 and encourage adopting healthy lifestyle habits.
Drug Topics
AUGUST 9, 2023
DHIs, first classified by the World Health Organization in 2018, include telemedicine, mobile health, wearable technologies, and artificial intelligence algorithms.
Drug Topics
JULY 14, 2023
A Kaiser Family Foundation analysis found the 10 drugs accounted for more than half of the increase in gross Part D spending from 2018 to 2021.
Fierce Healthcare
OCTOBER 25, 2023
New survey data from the Centers for Disease Control and Prevention (CDC) is reinforcing doctors’ warnings that the medical field is crumbling under a largely unaddressed mental health crisis and a | Survey data outlining healthcare workers' worsening mental health and workplace difficulties comes alongside new calls for action from the CDC and (..)
Pharmacy Times
FEBRUARY 9, 2024
Between 2018 and 2021, kindergarten-readiness dropped by 10%.
PharmaVoice
JANUARY 3, 2025
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end of recent annual tallies.
STAT
OCTOBER 26, 2023
Researchers compared survey data from 2018 and 2022, finding that health workers experienced poorer mental health outcomes post-pandemic. Of those surveyed, 46% of health workers reported feeling burnout often or very often in 2022, compared to 32% in 2018. Read the rest…
STAT
SEPTEMBER 24, 2024
Then, in 2018, she finally found a drug that kept her ADHD in check. STAT is co-publishing this article by Tradeoffs. Lisa Ann Trainor struggled to stay on top of schoolwork, hold a job or even perform basic tasks like laundry for six exhausting years. Continue to STAT+ to read the full story…
Fierce Pharma
FEBRUARY 8, 2024
After reaching a settlement with Minnesota’s attorney general, Eli Lilly can close the book on a yearslong lawsuit in the state. | The company will provide its insulin products at $35 per month and donate free insulin at 15 clinics over the next five years. Meanwhile, Minnesota's claims against Novo Nordisk and Sanofi remain ongoing.
STAT
FEBRUARY 27, 2025
In 2018, the Food and Drug Administration Safety and Innovation Act (FDASIA) authorized the FDA to apply an accelerated approval mechanism more broadly and created the breakthrough therapy designation, both of which would likely have been considered faster horses by Henry Ford.
STAT
MAY 14, 2024
WASHINGTON — On a bright June day in 2018, one of the nation’s top regulators waved groceries in the air, quizzing the secretary of agriculture on which agency is charged with monitoring different types of food.
Fierce Healthcare
FEBRUARY 4, 2025
A federal appeals court axed a $650 million judgment and corresponding injunction against CVS Pharmacy, Walgreens Boots Alliance and Walmart stemming from a lawsuit filed by two Ohio counties in 2018.
STAT
AUGUST 19, 2024
These firms — which pool funds from wealthy investors and are exempt from many of the regulations and disclosure requirements that apply to other types of investments — have spent a half-trillion dollars since 2018 buying up medical resources.
Pharmacy Times
DECEMBER 15, 2022
While the use of direct-acting antiviral treatment for hepatitis C virus increased from 2014 to 2018, treatment rates have declined since 2019 and remain suboptimal.
Pharmacy Times
MAY 16, 2023
Since the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.
STAT
JUNE 3, 2024
Other countries recognized the problem earlier: the United Kingdom appointed a minister for loneliness in 2018; Japan did the same in 2021. It’s been one year since the U.S. surgeon general issued a national warning about an epidemic of loneliness.
Drug Store News
OCTOBER 20, 2023
Flu activity is 66% lower than this time last year, but it is 34% higher when looking at pre-pandemic seasons, such as 2018-2019.
STAT
JULY 5, 2024
million patients with type 2 diabetes from 2005 to 2018 who were prescribed GLP-1s, insulin, or metformin. New research finds that the GLP-1 class of drugs — glucagon-like peptide receptor agonists — is more effective in mitigating the risk of 10 obesity-associated cancers than its type 2 diabetes drug alternatives.
STAT
DECEMBER 4, 2023
The proposal would reauthorize a number of programs first created by the SUPPORT Act, an addiction-focused bill that Congress first passed in 2018.
STAT
AUGUST 31, 2023
The first miscarriage happened in June 2018, almost as soon as she found out she was pregnant. — By the time Taylor Teske came to be sitting on an exam table in an obstetrician’s office in Minnesota, her medical records marked a devastating journey: nine pregnancies, one baby, eight miscarriages.
STAT
NOVEMBER 22, 2023
Overdose deaths among pregnant or postpartum people skyrocketed between 2018 and 2021, according to new research published Wednesday in JAMA Psychiatry.
STAT
FEBRUARY 3, 2024
Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.
pharmaphorum
DECEMBER 7, 2023
billion to buy central nervous system drug specialist Cerevel Therapeutics which spun out of Pfizer in 2018. AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7
STAT
FEBRUARY 15, 2024
WASHINGTON — A new trove of internal emails and other documents from the e-cigarette maker Juul reveals the company’s extensive behind-the-scenes efforts to promote its interests in Washington — a rare insight into the otherwise opaque methods corporations use to influence the government.
Pharmaceutical Technology
NOVEMBER 26, 2024
Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.
STAT
DECEMBER 14, 2023
Whichever the case, product recalls by the Food and Drug Administration and the Consumer Product Safety Commission (CPSC) more than doubled between 2018 and 2022, according to new research published on Wednesday by life sciences software company MasterControl. In 2018, the agency only recalled 22 products. In 2022, it recalled 310.
STAT
JUNE 7, 2024
They estimated that somewhere between 52,480 and 55,710 people in California died prematurely between 2008-2018 due to chronic exposure to the dangerous particulate matter in wildfire smoke. In a paper published Friday in Science Advances , researchers at UCLA Fielding School of Public Health tried to chip away at that knowledge gap.
STAT
MAY 6, 2024
Abrams, a frequent commentator about vaping in the news media, including CBS This Morning, CNN, and The New Yorker, coordinated extensively with Juul on public messaging in 2017 and 2018, according to company emails.
Fierce Healthcare
NOVEMBER 2, 2023
The Centers for Medicare & Medicaid Services has dropped the final rule to remedy the invalidated 340B-acquired drug payment policy for calendar years 2018 to 2022. |
STAT
JUNE 13, 2024
” So read the headline of a front-page story in The New York Times in 2018 on a dramatic step Chile was taking to fight obesity. “In Sweeping War on Obesity, Chile slays Tony the Tiger.”
Pharmacy Times
NOVEMBER 27, 2023
The study authors reported that plans in the South had the highest rates of exclusive PAs for either emtricitabine/tenofovir disoproxil fumarate or emtricitabine/tenofovir alafenamide even if the plan covered both, from 2018 to 2020.
STAT
JANUARY 7, 2024
Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. But in biotech, one of the most well-funded AI players has been quiet.
STAT
JANUARY 10, 2024
But since Verve Therapeutics was founded in 2018, it’s had a wider aperture: using the molecular tools of genome editing to go after the most common cause of death in the world. Morgan Healthcare Conference in San Francisco this week.
STAT
APRIL 18, 2024
The biotech is also being led by Spark Therapeutics co-founder Steven Altschuler, who joined Ziff Capital in 2018 as its managing director of health care ventures. Corner Therapeutics’ Series A round was led by Ziff Capital Partners, a little-known family office started by billionaire Dirk Ziff.
STAT
SEPTEMBER 18, 2023
Universities have also expanded their course offerings, with the number of new students enrolled in accredited midwifery programs growing from 1,006 students in 2014 to 1,214 in 2018 , according to the latest data available. Read the rest…
STAT
SEPTEMBER 14, 2023
Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.
STAT
OCTOBER 8, 2024
He rose to international infamy in 2018, when it came to light that he had performed a series of secretive, ethically fraught , scientifically sloppy genetic experiments that resulted in the birth of three CRISPR’d children.
STAT
FEBRUARY 7, 2024
At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content